Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypochondroplasia”

13 trials

Showing 13 of 13 results

Testing effectiveness (Phase 2)Looking for participantsNCT07126262
What this trial is testing

Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

Who this might be right for
Hypochondroplasia
BioMarin Pharmaceutical 60
Not applicableLooking for participantsNCT07388966
What this trial is testing

Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

Who this might be right for
AchondroplasiaHypochondroplasia
SYSNAV 140
Not applicableStudy completedNCT01435629
What this trial is testing

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

Who this might be right for
Genetic DisorderAchondroplasia
Novo Nordisk A/S 81
Not applicableLooking for participantsNCT06212947
What this trial is testing

Multinational Observational Study of Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
BioMarin Pharmaceutical 400
Large-scale testing (Phase 3)Enrolling By InvitationNCT07073014
What this trial is testing

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
BioMarin Pharmaceutical 140
Large-scale testing (Phase 3)Enrolling By InvitationNCT06873035
What this trial is testing

An Interventional Study of Infigratinib in Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 24
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07393373
What this trial is testing

Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 135
Not applicableLooking for participantsNCT05328050
What this trial is testing

Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

Who this might be right for
AchondroplasiaHypochondroplasia
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 200
Not applicableLooking for participantsNCT06410976
What this trial is testing

Prospective Clinical Assessment Study in Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04219007
What this trial is testing

Vosoritide for Selected Genetic Causes of Short Stature

Who this might be right for
Short Stature
Andrew Dauber 56
Not applicableStudy completedNCT01541306
What this trial is testing

C-Type Natriuretic Peptide and Achondroplasia

Who this might be right for
AchondroplasiaHypochondroplasia
Nemours Children's Clinic 91
Testing effectiveness (Phase 2)Study completedNCT01111019
What this trial is testing

Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children

Who this might be right for
Hypochondroplasia
Merck KGaA, Darmstadt, Germany 19
Large-scale testing (Phase 3)Active Not RecruitingNCT06455059
What this trial is testing

Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
BioMarin Pharmaceutical 80

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation